Clinical Trial: Safety and Efficacy of Sequential Treatment with Mexidol(R) in Patients with Chronic Cerebral Ischemia

U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT06834490) titled 'Safety and Efficacy of Sequential Treatment with Mexidol(R) in Patients with Chronic Cerebral Ischemia' on Feb. 11.

Brief Summary: The purpose of this study is to evaluate safety and efficacy of sequential treatment with Mexidol(R) in patients with chronic cerebral ischemia (CCI).

Study Start Date: Nov. 05, 2019

Study Type: INTERVENTIONAL

Condition: Chronic Cerebral Ischemia

Intervention: DRUG: Mexidol

50 mg/ml IV solution, 250 mg tablets

DRUG: Placebo

Placebo IV solution, Placebo tablets

Recruitment Status: COMPLETED

Sponsor: Pharmasoft

Published by HT Digital Content Services with permission from Health Daily Digest....